The Role of Inositol Hexakisphosphate Kinase in the Central Nervous System

Overview

Journal Biomolecules

Publisher MDPI

Specialties Biochemistry
Molecular Biology

Date 2023 Sep 28

PMID 37759717

Authors

Tyler Heitmann

James C Barrow

Affiliations

Soon will be listed here.

Abstract

Inositol is a unique biological small molecule that can be phosphorylated or even further pyrophosphorylated on each of its six hydroxyl groups. These numerous phosphorylation states of inositol along with the kinases and phosphatases that interconvert them comprise the inositol phosphate signaling pathway. Inositol hexakisphosphate kinases, or IP6Ks, convert the fully mono-phosphorylated inositol to the pyrophosphate 5-IP7 (also denoted IP7). There are three isoforms of IP6K: IP6K1, 2, and 3. Decades of work have established a central role for IP6Ks in cell signaling. Genetic and pharmacologic manipulation of IP6Ks in vivo and in vitro has shown their importance in metabolic disease, chronic kidney disease, insulin signaling, phosphate homeostasis, and numerous other cellular and physiologic processes. In addition to these peripheral processes, a growing body of literature has shown the role of IP6Ks in the central nervous system (CNS). IP6Ks have a key role in synaptic vesicle regulation, Akt/GSK3 signaling, neuronal migration, cell death, autophagy, nuclear translocation, and phosphate homeostasis. IP6Ks' regulation of these cellular processes has functional implications in vivo in behavior and CNS anatomy.

Citing Articles

Application of proton magnetic resonance spectroscopy in metabolic alterations of prefrontal white and gray matter in depression adolescents.

Zou Y, Wu Y, Han Y, He X, Zhao J World J Psychiatry. 2024; 14(11):1652-1660.

PMID: 39564168 PMC: 11572670. DOI: 10.5498/wjp.v14.i11.1652.

Kcs1 and Vip1: The Key Enzymes behind Inositol Pyrophosphate Signaling in .

Gogianu L, Ruta L, Farcasanu I Biomolecules. 2024; 14(2).

PMID: 38397389 PMC: 10886477. DOI: 10.3390/biom14020152.

Fragment-Based Screening Identifies New Quinazolinone-Based Inositol Hexakisphosphate Kinase (IP6K) Inhibitors.

Heitmann T, Liao G, de Leon P, Ernst G, Buchler I, Wei H ACS Med Chem Lett. 2023; 14(12):1760-1766.

PMID: 38116421 PMC: 10726443. DOI: 10.1021/acsmedchemlett.3c00409.

References

Clayton E, Sue N, Smillie K, OLeary T, Bache N, Cheung G . Dynamin I phosphorylation by GSK3 controls activity-dependent bulk endocytosis of synaptic vesicles. Nat Neurosci. 2010; 13(7):845-51. PMC: 2894011. DOI: 10.1038/nn.2571. View

Moritoh Y, Abe S, Akiyama H, Kobayashi A, Koyama R, Hara R . The enzymatic activity of inositol hexakisphosphate kinase controls circulating phosphate in mammals. Nat Commun. 2021; 12(1):4847. PMC: 8358040. DOI: 10.1038/s41467-021-24934-8. View

Boregowda S, Ghoshal S, Booker C, Krishnappa V, Chakraborty A, Phinney D . IP6K1 Reduces Mesenchymal Stem/Stromal Cell Fitness and Potentiates High Fat Diet-Induced Skeletal Involution. Stem Cells. 2017; 35(8):1973-1983. PMC: 5533188. DOI: 10.1002/stem.2645. View

Li X, Gu C, Hostachy S, Sahu S, Wittwer C, Jessen H . Control of XPR1-dependent cellular phosphate efflux by InsP is an exemplar for functionally-exclusive inositol pyrophosphate signaling. Proc Natl Acad Sci U S A. 2020; 117(7):3568-3574. PMC: 7035621. DOI: 10.1073/pnas.1908830117. View

Qi J, Cheng W, Gao Z, Chen Y, Shipton M, Furkert D . Itraconazole inhibits endothelial cell migration by disrupting inositol pyrophosphate-dependent focal adhesion dynamics and cytoskeletal remodeling. Biomed Pharmacother. 2023; 161:114449. PMC: 7614367. DOI: 10.1016/j.biopha.2023.114449. View

Giovannini D, Touhami J, Charnet P, Sitbon M, Battini J . Inorganic phosphate export by the retrovirus receptor XPR1 in metazoans. Cell Rep. 2013; 3(6):1866-73. DOI: 10.1016/j.celrep.2013.05.035. View

Wu M, Dul B, Trevisan A, Fiedler D . Synthesis and characterization of non-hydrolysable diphosphoinositol polyphosphate second messengers. Chem Sci. 2013; 4(1):405-410. PMC: 3558982. DOI: 10.1039/C2SC21553E. View

Qi J, Shi L, Zhu L, Chen Y, Zhu H, Cheng W . Functions, Mechanisms, and therapeutic applications of the inositol pyrophosphates 5PP-InsP and InsP in mammalian cells. J Cardiovasc Transl Res. 2023; 17(1):197-215. DOI: 10.1007/s12265-023-10427-0. View

Rao F, Xu J, Fu C, Cha J, Gadalla M, Xu R . Inositol pyrophosphates promote tumor growth and metastasis by antagonizing liver kinase B1. Proc Natl Acad Sci U S A. 2015; 112(6):1773-8. PMC: 4330756. DOI: 10.1073/pnas.1424642112. View

10.

Szijgyarto Z, Garedew A, Azevedo C, Saiardi A . Influence of inositol pyrophosphates on cellular energy dynamics. Science. 2011; 334(6057):802-5. DOI: 10.1126/science.1211908. View

11.

Nagata E, Saiardi A, Tsukamoto H, Satoh T, Itoh Y, Itoh J . Inositol hexakisphosphate kinases promote autophagy. Int J Biochem Cell Biol. 2010; 42(12):2065-71. DOI: 10.1016/j.biocel.2010.09.013. View

12.

Hou Q, Liu F, Chakraborty A, Jia Y, Prasad A, Yu H . Inhibition of IP6K1 suppresses neutrophil-mediated pulmonary damage in bacterial pneumonia. Sci Transl Med. 2018; 10(435). PMC: 6435359. DOI: 10.1126/scitranslmed.aal4045. View

13.

Emamian E, Hall D, Birnbaum M, Karayiorgou M, Gogos J . Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat Genet. 2004; 36(2):131-7. DOI: 10.1038/ng1296. View

14.

Liao G, Ye W, Heitmann T, Ernst G, DePasquale M, Xu L . Identification of Small-Molecule Inhibitors of Human Inositol Hexakisphosphate Kinases by High-Throughput Screening. ACS Pharmacol Transl Sci. 2021; 4(2):780-789. PMC: 8033760. DOI: 10.1021/acsptsci.0c00218. View

15.

Chakraborty A, Werner Jr J, Koldobskiy M, Mustafa A, Juluri K, Pietropaoli J . Casein kinase-2 mediates cell survival through phosphorylation and degradation of inositol hexakisphosphate kinase-2. Proc Natl Acad Sci U S A. 2011; 108(6):2205-9. PMC: 3038742. DOI: 10.1073/pnas.1019381108. View

16.

Li H, Yeh P, Chiu H, Tang C, Tu B . Hyperphosphorylation as a defense mechanism to reduce TDP-43 aggregation. PLoS One. 2011; 6(8):e23075. PMC: 3151276. DOI: 10.1371/journal.pone.0023075. View

17.

Park S, Park H, Kim M, Zhang S, Park S, Kim S . Inositol Pyrophosphate Metabolism Regulates Presynaptic Vesicle Cycling at Central Synapses. iScience. 2020; 23(4):101000. PMC: 7132149. DOI: 10.1016/j.isci.2020.101000. View

18.

Ahn M, Park S, Choi J, Choi J, Choi D, An D . Synthesis and biological evaluation of flavonoid-based IP6K2 inhibitors. J Enzyme Inhib Med Chem. 2023; 38(1):2193866. PMC: 10075506. DOI: 10.1080/14756366.2023.2193866. View

19.

Minini M, Senni A, Unfer V, Bizzarri M . The Key Role of IPK: A Novel Target for Anticancer Treatments?. Molecules. 2020; 25(19). PMC: 7583815. DOI: 10.3390/molecules25194401. View

20.

Norris F, Ungewickell E, MAJERUS P . Inositol hexakisphosphate binds to clathrin assembly protein 3 (AP-3/AP180) and inhibits clathrin cage assembly in vitro. J Biol Chem. 1995; 270(1):214-7. DOI: 10.1074/jbc.270.1.214. View